Undisclosed Novel Strategy
Type 1 Diabetes
Pre-clinicalEarly Research
Key Facts
About CG Scientific
CG Scientific Inc. is a private, early-stage biotech company dedicated to creating a breakthrough treatment for type 1 diabetes. The company operates from its headquarters in Worcester, Massachusetts, and is actively seeking investment opportunities to advance its novel therapeutic approach. While specific details about its technology platform and pipeline remain undisclosed on its public website, the company's mission centers on addressing the significant unmet medical need in autoimmune diabetes treatment. CG Scientific represents a promising venture in the competitive diabetes therapeutics landscape.
View full company profileTherapeutic Areas
Other Type 1 Diabetes Drugs
| Drug | Company | Phase |
|---|---|---|
| VX-880 | Vertex Pharmaceuticals | Phase 1/2 |
| VCTX210 (Vertex collab.) | CRISPR Therapeutics | Phase 1/2 |
| UP421 | Sana Biotechnology | Pre-Clinical |
| SC451 | Sana Biotechnology | Pre-Clinical |
| BioVascular Pancreas™ | Humacyte | Preclinical |
| ORMD-0801 | Oramed Pharmaceuticals | Phase 2 |